<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:department>UNLISTED</gtr:department><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD"><gtr:id>59EE6C94-CB2C-4AB3-9A0B-EAAF5A6550CD</gtr:id><gtr:name>The Pirbright Institute</gtr:name><gtr:address><gtr:line1>Ash Road</gtr:line1><gtr:line2>Pirbright</gtr:line2><gtr:line4>Woking</gtr:line4><gtr:line5>Surrrey</gtr:line5><gtr:postCode>GU24 0NF</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/1C2EEA30-8EDC-4335-B896-240E712D2D9C"><gtr:id>1C2EEA30-8EDC-4335-B896-240E712D2D9C</gtr:id><gtr:firstName>Neil</gtr:firstName><gtr:otherNames>Andrew</gtr:otherNames><gtr:surname>Mabbott</gtr:surname><gtr:orcidId>0000-0001-7395-1796</gtr:orcidId><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FD00831X%2F1"><gtr:id>7F619C86-7BCB-43BE-9302-57A9067E9EEB</gtr:id><gtr:title>Investigating the role of follicular dendritic cells in TSE agent neuroinvasion from lymphoid tissues</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/D00831X/1</gtr:grantReference><gtr:abstractText>Transmissible spongiform encephalophathies (TSEs) are fatal neurodegenerative diseases. Examples include Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform encephalopathy (BSE), chronic wasting disease (CWD) in mule deer and elk, and scrapie in sheep and goats. Most natural transmissions of TSE agents occur by peripheral exposure, eg: ingestion (oral). After inoculation, TSE agents usually accumulate upon follicular dendritic cells (FDCs) in lymphoid tissues before they infect the central nervous system (CNS). FDCs are critical for the spread of disease to the CNS (neuroinvasion) as in their absence agent accumulation in lymphoid tissues and neuroinvasion are impaired. The nature of the TSE agent is not known, but an abnormal isoform (PrPSc) of the host cellular prion protein (PrPc), co-purifies with infectivity. Indeed, PrPSc is detected upon FDCs after inoculation with some TSE agents. Cells must express cellular PrPc to replicate TSE agents. Although PrPc is detected on FDCs in uninfected mice, it is not known if FDCs express PrPc and replicate TSE agents. Treatments that deplete FDCs reduce susceptibility to TSE agents. Thus, a thorough understanding of the involvement of FDCs in TSE pathogenesis is important when determining risk, and designing therapeutic strategies against peripherally-acquired TSEs. FDCs trap and retain native antigens on their surfaces for long durations. Thus their involvement in TSE pathogenesis may be to trap TSE agents released from infected cells and mediate their transfer to neurones. Many cell types secrete exosomes enriched in cell-specific protein. FDCs can bind exosomes, and as a consequence display proteins on their surfaces that they do not express at the mRNA level. PrPc and PrPSc can be released in exosomes, providing a mechanism by which FDCs might acquire PrPc and TSE agents from other infected cells. Experiments have excluded bone marrow-derived cells as major providers of the PrPc and PrPSc detected on FDCs. However, the involvement of non-haematopoietic cells (eg: muscle, endothelial, epithelial or nerve cells) cannot be excluded. We will use novel approaches to provide important information on FDC biology and their involvement in TSE pathogenesis. In particular we will address the following objectives: O-1: Do FDCs express PrPc or acquire it from other host cells? O-2: Do FDCs replicate TSE agents, or acquire them from other infected host cells? Increased understanding of the FDCs involvement in TSE pathogenesis may aid the development of therapeutic strategies.</gtr:abstractText><gtr:technicalSummary>Transmissible spongiform encephalophathies (TSEs) are fatal neurodegenerative diseases. Examples include Creutzfeldt-Jakob disease (CJD) in humans, bovine spongiform encephalopathy (BSE), chronic wasting disease (CWD) in mule deer and elk, and scrapie in sheep and goats. Most natural transmissions of TSE agents occur by peripheral exposure, eg: ingestion (oral). After inoculation, TSE agents usually accumulate upon follicular dendritic cells (FDCs) in lymphoid tissues before they infect the central nervous system (CNS). FDCs are critical for the spread of disease to the CNS (neuroinvasion) as in their absence agent accumulation in lymphoid tissues and neuroinvasion are impaired. The nature of the TSE agent is not known, but an abnormal isoform (PrPSc) of the host cellular prion protein (PrPc), co-purifies with infectivity. Indeed, PrPSc is detected upon FDCs after inoculation with some TSE agents. Cells must express cellular PrPc to replicate TSE agents. Although PrPc is detected on FDCs in uninfected mice, it is not known if FDCs express PrPc and replicate TSE agents. Treatments that deplete FDCs reduce susceptibility to TSE agents. Thus, a thorough understanding of the involvement of FDCs in TSE pathogenesis is important when determining risk, and designing therapeutic strategies against peripherally-acquired TSEs. FDCs trap and retain native antigens on their surfaces for long durations. Thus their involvement in TSE pathogenesis may be to trap TSE agents released from infected cells and mediate their transfer to neurones. Many cell types secrete exosomes enriched in cell-specific protein. FDCs can bind exosomes, and as a consequence display proteins on their surfaces that they do not express at the mRNA level. PrPc and PrPSc can be released in exosomes, providing a mechanism by which FDCs might acquire PrPc and TSE agents from other infected cells. Experiments have excluded bone marrow-derived cells as major providers of the PrPc and PrPSc detected on FDCs. However, the involvement of non-haematopoietic cells (eg: muscle, endothelial, epithelial or nerve cells) cannot be excluded. We will use novel approaches to provide important information on FDC biology and their involvement in TSE pathogenesis. In particular we will address the following objectives: O-1: Do FDCs express PrPc or acquire it from other host cells? O-2: Do FDCs replicate TSE agents, or acquire them from other infected host cells? Increased understanding of the FDCs involvement in TSE pathogenesis may aid the development of therapeutic strategies.</gtr:technicalSummary><gtr:fund><gtr:end>2007-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2006-09-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>272166</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>-Demonstrated for the first time that follicular dendritic cells alone are the important sites of TSE agent accumulation in lymphoid tissues.



-Demonstrated for the first time that the specific ablation of PrPC expression only on FDC blocked TSE agent accumulation in lymphoid tissues and subsequent neuroinvasion.</gtr:description><gtr:id>C47676E1-0440-4966-9DD1-9C4B0EE1D461</gtr:id><gtr:outcomeId>r-3368869175.546681779de1fa</gtr:outcomeId><gtr:sectors/></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>E07C6266-A794-4D44-A00E-E3C3C0736146</gtr:id><gtr:title>Immunology of Prion Protein and Prions.</gtr:title><gtr:parentPublicationTitle>Progress in molecular biology and translational science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1877-1173</gtr:issn><gtr:outcomeId>5a85a3c46df934.26236870</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>90505937-5BC8-458A-8667-EED77C153047</gtr:id><gtr:title>B cell-specific S1PR1 deficiency blocks prion dissemination between secondary lymphoid organs.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8bf108f93a0fafc59f36df35e5c04fb2"><gtr:id>8bf108f93a0fafc59f36df35e5c04fb2</gtr:id><gtr:otherNames>Mok SW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>545a1f5bb73888.97559555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE30977C-DE6C-45D7-AE2A-0B8AE5A1FEEC</gtr:id><gtr:title>The role of follicular dendritic cells in scrapie pathogenesis</gtr:title><gtr:parentPublicationTitle>Joint Funders TSE Workshop</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/58b50b85a5c5aa4a8934730e2b33cb29"><gtr:id>58b50b85a5c5aa4a8934730e2b33cb29</gtr:id><gtr:otherNames>McCulloch, L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>5432c5e7e2a7c8.24286879</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B2B7A5FB-7918-4D82-BCA1-82E4702D9429</gtr:id><gtr:title>Human prion diseases and the risk of their transmission during anatomical dissection.</gtr:title><gtr:parentPublicationTitle>Clinical anatomy (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e48b28ee4ab00aac6a546646ce68a2b"><gtr:id>4e48b28ee4ab00aac6a546646ce68a2b</gtr:id><gtr:otherNames>Bradford BM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0897-3806</gtr:issn><gtr:outcomeId>5432b1b2da2698.55381044</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5E5399BE-0CA0-461D-BC0F-4888CCB3C12D</gtr:id><gtr:title>MicroRNA-100-5p indirectly modulates the expression of Il6, Ptgs1/2 and Tlr4 mRNA in the mouse follicular dendritic cell-like cell line, FL-Y.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/432fa25d6fd8502375d2d09b60c08e83"><gtr:id>432fa25d6fd8502375d2d09b60c08e83</gtr:id><gtr:otherNames>Aungier SR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>545a1dc6062fa8.16237171</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D12D720-DFD9-4F7E-802E-3EE46D9C03B8</gtr:id><gtr:title>The effects of host age on the transport of complement-bound complexes to the spleen and the pathogenesis of intravenous scrapie infection.</gtr:title><gtr:parentPublicationTitle>Journal of virology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/700fbb235965330040dfaa9897517a46"><gtr:id>700fbb235965330040dfaa9897517a46</gtr:id><gtr:otherNames>Brown KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0022-538X</gtr:issn><gtr:outcomeId>5432c3472c9cf1.43468237</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6DCC2810-A592-4102-AC4C-C675FDE57713</gtr:id><gtr:title>Prospects for safe and effective vaccines against prion diseases.</gtr:title><gtr:parentPublicationTitle>Expert review of vaccines</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1476-0584</gtr:issn><gtr:outcomeId>545a1d541561c1.00042851</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D0BBCD5-3BBB-4CD0-954C-13F862E61F3D</gtr:id><gtr:title>Investigating the role of follicular dendritic cells (FDCs) in scrapie pathogenesis</gtr:title><gtr:parentPublicationTitle>14th International Congress of Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8c2bf5df51144d8a9301e67d5a7f4c0c"><gtr:id>8c2bf5df51144d8a9301e67d5a7f4c0c</gtr:id><gtr:otherNames>McCulloch, L.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>5432c63cd037b0.91599206</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A6260C5-E0FD-415B-837C-B4E9E84C8F26</gtr:id><gtr:title>Determining the influence of the host immune system on TSE pathogenesis</gtr:title><gtr:parentPublicationTitle>EBRC Launch</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7b32c6588e86101875805ed943e120df"><gtr:id>7b32c6588e86101875805ed943e120df</gtr:id><gtr:otherNames>MAbbott, N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:outcomeId>5432b9d34f9a59.02260776</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>607A2599-A3BD-40C4-B32D-240B5C330C48</gtr:id><gtr:title>Scrapie affects the maturation cycle and immune complex trapping by follicular dendritic cells in mice.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4335586719899bb90725ae0077acc26"><gtr:id>a4335586719899bb90725ae0077acc26</gtr:id><gtr:otherNames>McGovern G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>5432c4b48e4ce1.02394329</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8DDDBF5E-C9E8-4E7E-A367-C353CF25DF89</gtr:id><gtr:title>Follicular dendritic cell-specific prion protein (PrP) expression alone is sufficient to sustain prion infection in the spleen.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf9ca88eb9302095b0d8a372783d6bc3"><gtr:id>cf9ca88eb9302095b0d8a372783d6bc3</gtr:id><gtr:otherNames>McCulloch L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5432c405479943.07208668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C50561A9-7809-4B16-81E0-17FDD9A2C4F2</gtr:id><gtr:title>Clusterin expression in follicular dendritic cells associated with prion protein accumulation.</gtr:title><gtr:parentPublicationTitle>The Journal of pathology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcb9a592a95f7031a08f7d4cab6a3b97"><gtr:id>dcb9a592a95f7031a08f7d4cab6a3b97</gtr:id><gtr:otherNames>Sasaki K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-3417</gtr:issn><gtr:outcomeId>545a220966f4b4.29112587</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>73665B6F-36E2-4500-8B0D-0C979F14EB2B</gtr:id><gtr:title>Ablation of the cellular prion protein, PrPC, specifically on follicular dendritic cells has no effect on their maturation or function.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cf9ca88eb9302095b0d8a372783d6bc3"><gtr:id>cf9ca88eb9302095b0d8a372783d6bc3</gtr:id><gtr:otherNames>McCulloch L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>5432c48c2168b0.63673494</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CAB7438D-F4C9-471A-BC24-3923D76A1F16</gtr:id><gtr:title>Prions and their lethal journey to the brain.</gtr:title><gtr:parentPublicationTitle>Nature reviews. Microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1740-1526</gtr:issn><gtr:outcomeId>545a22093e6388.46126956</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A17C7CC-EFFE-4079-8EDE-7B0B4A4EAC03</gtr:id><gtr:title>Prion pathogenesis and secondary lymphoid organs (SLO): tracking the SLO spread of prions to the brain.</gtr:title><gtr:parentPublicationTitle>Prion</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1933-6896</gtr:issn><gtr:outcomeId>5432b3122a3cb0.30902370</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AE753DFB-2B3A-4DCB-8F73-BAD6718AFF23</gtr:id><gtr:title>Scrapie alters immune complex trapping and the maturation cycle of follicular dendritic cells</gtr:title><gtr:parentPublicationTitle>Prion 2009</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c7ae9e53dc7d88353438ca0c78449d1"><gtr:id>5c7ae9e53dc7d88353438ca0c78449d1</gtr:id><gtr:otherNames>McGovern, G.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>5432c702650fb8.21905668</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CC795B3-AC64-4A35-8BC7-F6BD02BAF8BA</gtr:id><gtr:title>Determining the role of follicular dendritic cells in scrapie pathogenesis</gtr:title><gtr:parentPublicationTitle>Prion 2009</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4cc7c28430e7151cd7bfae4d136dce5"><gtr:id>a4cc7c28430e7151cd7bfae4d136dce5</gtr:id><gtr:otherNames>Mucculloch, L.</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>5432c56d4b6ae1.41967861</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>266BAC87-5D92-4D56-A809-86F10B8C0D50</gtr:id><gtr:title>Prion uptake in the gut: identification of the first uptake and replication sites.</gtr:title><gtr:parentPublicationTitle>PLoS pathogens</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dc712debcc9f619fdfa52f736c1722dd"><gtr:id>dc712debcc9f619fdfa52f736c1722dd</gtr:id><gtr:otherNames>Kujala P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1553-7366</gtr:issn><gtr:outcomeId>5432bc7591fe84.34905292</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DEF08884-A9AC-4E59-B95D-79077DFBD815</gtr:id><gtr:title>Identification of co-expressed gene signatures in mouse B1, marginal zone and B2 B-cell populations.</gtr:title><gtr:parentPublicationTitle>Immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2671cbcc0eb0e80e6b60b9771fd2ad92"><gtr:id>2671cbcc0eb0e80e6b60b9771fd2ad92</gtr:id><gtr:otherNames>Mabbott NA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0019-2805</gtr:issn><gtr:outcomeId>545a1e7c3c8c19.93781194</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>83FEFD0F-193C-4E2F-8754-0EEF516DAF96</gtr:id><gtr:title>The effects of host age on follicular dendritic cell status dramatically impair scrapie agent neuroinvasion in aged mice.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/700fbb235965330040dfaa9897517a46"><gtr:id>700fbb235965330040dfaa9897517a46</gtr:id><gtr:otherNames>Brown KL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>545a20134a8346.88907013</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/D00831X/1</gtr:identifier></gtr:identifiers><gtr:projectHierarchy><gtr:parents><gtr:parent><gtr:id>7F619C86-7BCB-43BE-9302-57A9067E9EEB</gtr:id><gtr:grantRef>BB/D00831X/1</gtr:grantRef><gtr:amount>272166.4</gtr:amount><gtr:start>2006-09-01</gtr:start><gtr:end>2007-03-31</gtr:end><gtr:children><gtr:child rel="Transfer"><gtr:id>38643660-0774-4FE2-B39A-8701ADBAEA95</gtr:id><gtr:grantRef>BB/D00831X/2</gtr:grantRef><gtr:amount>232508.5</gtr:amount><gtr:start>2007-04-01</gtr:start><gtr:end>2008-04-30</gtr:end><gtr:children><gtr:child rel="Transfer"><gtr:id>A20B2CD3-EF9C-4046-ACF8-2D08CDE8ACE4</gtr:id><gtr:grantRef>BB/D00831X/3</gtr:grantRef><gtr:amount>162385.63</gtr:amount><gtr:start>2008-05-01</gtr:start><gtr:end>2010-02-28</gtr:end><gtr:children/></gtr:child></gtr:children></gtr:child></gtr:children></gtr:parent></gtr:parents></gtr:projectHierarchy><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>